180 Life Sciences Corp.
ATNF
$3.00
$0.8740.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.22M | 3.72M | 4.59M | 194.90K | 1.15M |
| Total Receivables | 10.80K | 10.00K | 41.20K | 44.30K | 10.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 802.70K | 294.20K | 515.00K | 986.10K | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 60.30K | -- | -- | -- | -- |
| Total Current Assets | 3.09M | 4.03M | 5.14M | 1.23M | 2.35M |
|
|
|||||
| Total Current Assets | 3.09M | 4.03M | 5.14M | 1.23M | 2.35M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 7.62M | 7.62M | 7.62M | 9.24M | 1.56M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.71M | 11.65M | 12.76M | 10.47M | 3.91M |
|
|
|||||
| Total Accounts Payable | 3.30M | 3.02M | 2.62M | 2.67M | 2.92M |
| Total Accrued Expenses | 623.70K | 521.10K | 439.70K | 466.30K | 667.20K |
| Short-term Debt | -- | -- | 134.90K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.41M | 148.40K | 13.00K | 473.10K | 429.00K |
| Total Finance Division Other Current Liabilities | -- | 250.00K | 300.00K | 2.77M | -- |
| Total Other Current Liabilities | -- | 250.00K | 300.00K | 2.77M | -- |
| Total Current Liabilities | 5.33M | 3.94M | 3.50M | 6.38M | 4.02M |
|
|
|||||
| Total Current Liabilities | 5.33M | 3.94M | 3.50M | 6.38M | 4.02M |
| Long-Term Debt | -- | 3.40K | 6.60K | 10.60K | 13.30K |
| Short-term Debt | -- | -- | 134.90K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 341.70K | 300.00K |
| Total Liabilities | 5.33M | 3.95M | 3.51M | 6.74M | 4.33M |
|
|
|||||
| Common Stock & APIC | 155.12M | 154.58M | 153.69M | 135.96M | 130.90M |
| Retained Earnings | -145.62M | -143.89M | -141.52M | -129.24M | -128.40M |
| Treasury Stock & Other | -4.13M | -2.98M | -2.92M | -2.98M | -2.92M |
| Total Common Equity | 5.38M | 7.71M | 9.25M | 3.73M | -418.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 100.00 | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 100.00 | -- | -- |
|
|
|||||
| Total Common Equity | 5.38M | 7.71M | 9.25M | 3.73M | -418.00K |
| Total Preferred Equity | -- | -- | 100.00 | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.38M | 7.71M | 9.25M | 3.73M | -418.00K |
|
|
|||||